RocketTickers

BSTC Announces Positive Topline Results from Phase1

Long
NASDAQ:BSTC   None
BSTC: BioSpecifics Technologies Corp.
2018-10-31 16:30:00
BioSpecifics Technologies Corp. Announces Positive Topline Results from Phase 1 Study of CCH for the Treatment of Uterine Fibroids
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.